Novogen Ltd (Other) (SC 13D/A)
September 20 2007 - 3:59PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 8)
NOVOGEN LIMITED
(Name of Issuer)
Sponsored ADR (each convertible into 5 Ordinary Shares)
(Title of Class of Securities)
67010F103
(CUSIP Number)
David J. Harris, Esq., 1775 I Street, N.W. Washington, D.C. 20006 (202) 261-3385
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
September 10, 2007
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].
|
|
|
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
|
1
|
NAME OF REPORTING PERSON
SS. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Josiah T. Austin
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
|
3
|
SEC USE ONLY
|
4
|
SOURCE OF FUNDS
OO and WC
|
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
|
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE VOTING POWER
38,400 Sponsored ADRs (representing 192,000 ordinary shares)
|
8
|
SHARED VOTING POWER
3,112,884 Sponsored ADRs (representing 15,564,420 ordinary shares)
|
9
|
SOLE DISPOSITIVE POWER
38,400 Sponsored ADRs (representing 192,000 ordinary shares)
|
10
|
SHARED DISPOSITIVE POWER
3,112,884 Sponsored ADRs (representing 15,564,420 ordinary shares)
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,151,284 Sponsored ADRs (representing 15,756,420 ordinary shares)
|
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ]
|
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
16.14%
|
14
|
TYPE OF REPORTING PERSON
IN
|
1
|
NAME OF REPORTING PERSON
SS. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
El Coronado Holdings, L.L.C.
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
|
3
|
SEC USE ONLY
|
4
|
SOURCE OF FUNDS
OO and WC
|
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
|
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Arizona
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE VOTING POWER
0
|
8
|
SHARED VOTING POWER
3,112,884 Sponsored ADRs (representing 15,564,420 ordinary shares)
|
9
|
SOLE DISPOSITIVE POWER
0
|
10
|
SHARED DISPOSITIVE POWER
3,112,884 Sponsored ADRs (representing 15,564,420 ordinary shares)
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,112,884 Sponsored ADRs (representing 15,564,420 ordinary shares)
|
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
[ ]
|
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
15.94%
|
14
|
TYPE OF REPORTING PERSON
HC
|
ITEM 1
.
|
Security and Issuer
.
|
|
|
|
|
This Amendment No. 8 to the Statement on Schedule 13D heretofore filed on November 18, 2004 is filed with respect to sponsored ADRs ("Sponsored ADRs"), each convertible into 5 ordinary shares ("Ordinary Shares") of Novogen Limited (the "Company"). The address of the Company is 140 Wicks Road, North Ryde, New South Wales 2113 C3 2113, 01161298780088. The Statement is being filed on behalf of Josiah T. Austin, a United States Citizen, and El Coronado Holdings, L.L.C. ("ECH"), an Arizona limited liability company whose principal place of business is 4673 Christopher Place, Dallas, Texas 75204 (collectively, the "Reporting Persons") to reflect the following amendments to Item 3 and Item 5.
|
|
|
|
ITEM 3
.
|
Source and Amount of Funds or Other Consideration
.
|
|
|
|
Item 3 is amended to include the following:
|
|
|
|
|
The total consideration (exclusive of brokers' commissions) for all Ordinary Shares subject to this Amendment No. 8 is $3,376,772.72. The Ordinary Shares herein reported as being beneficially owned by the Reporting Persons were acquired in the following manner:
|
|
|
|
|
Austin is the sole managing Member of ECH. Acting on behalf of ECH, Austin purchased on September 10, 2007 a total of 435,039 Sponsored ADRs (representing 2,175,195 Ordinary Shares) in an open market transaction for aggregate consideration (exclusive of brokers' commissions) of $3,376,772.72. The purchase was made through a brokerage firm, and the primary source of the funding for this purchase was available funds of ECH and margin obtained under standard terms and conditions margin agreements.
|
|
|
|
All dollar amounts are in United States dollars.
|
|
|
|
Item 5
.
|
Interest in Securities of the Issuer
.
|
|
|
|
(a)
|
Austin is the beneficial owner of 3,151,284 Sponsored ADRs (representing 15,756,420 Ordinary Shares, which is 16.14% based on the 97,594,261 Ordinary Shares outstanding as reported in the Company's Form 6-K, filed on August 24, 2007) as Trustee for certain family trusts and as sole Managing Member of ECH. ECH is the beneficial owner of 3,112,884 Sponsored ADRs (representing 15,564,420 Ordinary Shares, which is 15.94% based on the 97,594,261 Ordinary Shares outstanding as reported in the Company's Form 6-K, filed on August 24, 2007).
|
|
|
|
(b)
|
Austin has the sole power to vote or to direct the vote or to dispose or to direct the disposition of 38,400 Sponsored ADRs (representing 192,000 ordinary shares). As the sole Managing Member of ECH, Austin shares with ECH the power to vote or to direct the vote or to dispose or to direct the disposition of the 3,112,884 Sponsored ADRs (representing 15,564,420 ordinary shares) held by ECH.
|
|
|
|
(c)
|
Since July 11, 2007, ECH purchased an aggregate of 435,039 Sponsored ADRs (representing 2,175,195 Ordinary Shares) in a broker's transaction in the open market on September 10, 2007. The price, excluding brokerage fees, was $7.762 per Sponsored ADR.
|
|
|
|
(d)
|
No person other than the Reporting Persons, has any right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, such securities.
|
|
|
|
(e)
|
Not applicable.
|
Signature
|
|
|
After reasonable inquiry and to the best knowledge and belief, I certify that the information set forth in this Statement is true, complete and correct.
|
Date: September 20, 2007
|
/s/ Josiah T. Austin
|
|
Josiah T. Austin,
|
|
Individually and as Sole Managing Member of ECH
|
Kazia Therapeutics (NASDAQ:KZIA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Kazia Therapeutics (NASDAQ:KZIA)
Historical Stock Chart
From Jul 2023 to Jul 2024